The short answer on gene editing for cholesterol Yes, it is real. A single intravenous infusion of an experimental medicine called VERVE-102 used a precise form of CRISPR called base editing to switch off the PCSK9 gene in the liver. In the Phase 1 Heart-2 trial, LDL cholesterol fell by up to 62% in a […]